1 |
DOVEY S, MCINTYRE K, JACOBSON D, et al. Is a premature rise in luteinizing hormone in the absence of increased progesterone levels detrimental to pregnancy outcome in GnRH antagonist in vitro fertilization cycles[J]. Fertil Steril, 2011, 96(3): 585-589.
|
2 |
BOSCH E, VALENCIA I, ESCUDERO E, et al. Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome[J]. Fertil Steril,2003,80(6): 1444-1449.
|
3 |
ZHANG D D, ZHANG D, SUN Z Y, et al. The effect of a transient premature luteinizing hormone surge without elevated serum progesterone on in vitro fertilization outcomes in a gonadotropin-releasing hormone antagonist flexible protocol[J]. Gynecol Endocrinol, 2020, 36(6): 550-553.
|
4 |
中国女医师协会生殖医学专业委员会专家共识编写组, 李 蓉, 甄秀梅, 等. 辅助生殖领域拮抗剂方案标准化应用专家共识[J].中华生殖与避孕杂志,2022(2): 109-116.
|
5 |
ALPHA Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology. The Istanbul Consensus Workshop on Embryo Assessment: Proceedings of an expert meeting[J]. Hum Reprod, 2011, 26(6): 1270-1283.
|
6 |
BARRI P N, COROLEU B, MARTINEZ F, et al. Stimulation protocols for poor responders and aged women[J]. Mol Cell Endocrinol, 2000, 166(1): 15-20.
|
7 |
XIONG Y J, WANG J Z, LIU L, et al. Effects of high progesterone level on the day of human chorionic gonadotrophin administration in in vitro fertilization cycles on epigenetic modification of endometrium in the peri-implantation period[J]. Fertil Steril, 2017,108(2): 269-276.
|
8 |
FANG Y Y, WU Q J, ZHANG T N, et al. Assessment of the development of assisted reproductive technology in Liaoning Province of China, from 2012 to 2016[J]. BMC Health Serv Res, 2018, 18(1): 873.
|
9 |
WANG M, XI Q S, YANG Q Y, et al. The relationship between a novel evaluation parameter of premature luteinization and IVF outcomes[J]. Reprod Biomed Online, 2021, 42(2): 323-331.
|
10 |
肖 珊, 莫美兰, 刘 苏, 等. 多囊卵巢综合征患者拮抗剂方案中早发LH升高对IVF-ET临床结局的影响[J]. 生殖医学杂志, 2022, 31(1): 6-12.
|
11 |
叶 虹. 再论促黄体生成素峰[J]. 生殖医学杂志, 2010, 19(S1): 3-5.
|
12 |
FOROOZANFARD F, MORAVEJI S A, TAGHAVI S A,et al. Association between serum estradiol level on the day of hCG administration and IVF-ICSI outcome[J]. J Obstet Gynaecol India, 2016, 66(3): 170-173.
|
13 |
LUO X, PEI L, LI F J, et al. Fixed versus flexible antagonist protocol in women with predicted high ovarian response except PCOS: a randomized controlled trial[J]. BMC Pregnancy Childbirth, 2021, 21(1): 348.
|
14 |
DEPALO R, TREROTOLI P, CHINCOLI A, et al. Endogenous luteinizing hormone concentration and IVF outcome during ovarian stimulation in fixed versus flexible GnRH antagonist protocols: an RCT[J]. Int J Reprod Biomed, 2018, 16(3): 175-182.
|
15 |
罗克莉, 郭 慧, 龚 斐. 提早加用促性腺激素释放激素拮抗剂可改善低反应患者的助孕效果[J]. 实用医学杂志, 2012, 28(13): 2211-2213.
|
16 |
BONDUELLE M, OBERYÉ J, MANNAERTS B,et al.Large prospective, pregnancy and infant follow-up trial assures the health of 1000 fetuses conceived after treatment with the GnRH antagonist ganirelix during controlled ovarian stimulation[J]. Hum Reprod, 2010, 25(6): 1433-1440.
|
17 |
FLUKER M, GRIFO J, LEADER A, et al. Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation[J]. Fertil Steril, 2001, 75(1): 38-45.
|
18 |
王泽华, 王艳丽. 妇产科学[M]. 8版. 北京: 人民卫生出版社, 2019: 70.
|
19 |
梁晓燕,方丛,黄睿,等.辅助生殖技术实践与提高[M].北京:人民卫生出版社,2018:151.
|
20 |
SHIN J J, PARK K E, CHOI Y M, et al. Early gonadotropin-releasing hormone antagonist protocol in women with polycystic ovary syndrome: a preliminary randomized trial[J].Clin Exp Reprod Med,2018,45(3): 135-142.
|
21 |
CHEN Y, YE B L, YANG X J, et al. Predicting the outcome of different protocols of in vitro fertilization with anti-Muüllerian hormone levels in patients with polycystic ovary syndrome[J].J Int Med Res, 2017,45(3): 1138-1147.
|
22 |
HAMDINE O, BROEKMANS F J, EIJKEMANS M J C,et al. Early initiation of gonadotropin-releasing hormone antagonist treatment results in a more stable endocrine milieu during the mid- and late-follicular phases: a randomized controlled trial comparing gonadotropin-releasing hormone antagonist initiation on cycle day 2 or 6[J]. Fertil Steril, 2013, 100(3): 867-874.
|
23 |
LIN L T, WANG P H, TSUI K H. Early initiation of GnRH antagonist administration in a flexible protocol: is it better? [J]. J Chin Med Assoc, 2018, 81(1): 4-6.
|
24 |
WERTHEIMER A, DANIELI-GRUBER S, HOCHBERG A, et al. The association between treatment parameters on the day of gonadotropin-releasing hormone antagonist initiation during a flexible protocol and oocyte maturation rate[J]. Reprod Biol, 2020, 20(2): 127-131.
|
25 |
KOCHHAR P K, GHOSH P. Diminished ovarian reserve predisposes to premature luteinizing hormone surges in gonadotropin-releasing hormone antagonist cycles in in vitro fertilization[J]. J Hum Reprod Sci, 2020, 13(3): 191-195.
|
26 |
MESSINIS I E, MESSINI C I, ANIFANDIS G, et al. Gonadotropin surge-attenuating factor: a nonsteroidal ovarian hormone controlling GnRH-induced LH secretion in the normal menstrual cycle[J]. Vitam Horm, 2018, 107: 263-286.
|